Current position:Home >Product >
2-Piperidinecarboxylicacid,1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-,(2E,4R,6E,8R)-
2-Piperidinecarboxylicacid,1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-,(2E,4R,6E,8R)-(147438-27-5)
- Name: 2-Piperidinecarboxylicacid,1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-,(2E,4R,6E,8R)-
- Synonyms:2-Piperidinecarboxylicacid, 1-[oxo[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]acetyl]-(9CI); 2-Piperidinecarboxylic acid,1-[oxo[tetrahydro-2-hydroxy-6-[14-hydroxy-22-(4-hydroxy-3-methoxycyclohexyl)-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaenyl]-3-methyl-2H-pyran-2-yl]acetyl]-,[2R-[2a,2(S*),3a,6b[2S*,3E,5E,7E,9S*,11R*,13R*,14R*,15E,17R*,19E,21R*,22(1S*,3R*,4R*)]]]-;Secorapamycin A
- Molecular Formula:C51H79 N O13
- Molecular Weight:914.187
- CAS Registry Number:147438-27-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 157627-87-7/Fatty acids, C18-unsatd, dimers, polymers with triethylenetetramine
- 190912-82-4/Irganox B 1412
- 751-28-0/ISOOBACUNOICACID
- 68915-29-7/Polyphosphoric acids, Et esters, reaction products with epichlorohydrin
- 67106-14-3/4-hydroxy-2,5-diphenylcyclopent-4-ene-1,3-dione
- 93-02-7/2,5-Dimethoxybenzaldehyde
- 1734-62-9/LR-70
- 5436-77-1/2-[1-(benzylidene)hexyl]-4-methyl-1,3-dioxolane
- 54546-19-9/DEMB
- 111411-06-4/Neuropeptide I(Cardisoma carnifex sinus gland) (9CI)
- 75483-02-2/ethyl 4-(acetyloxy)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxylate
- 211802-28-7/Vilmorinin C
- 49555-48-8/1,4:3,6-Dianhydro-D-glucitol didodecanoate
- 10277-04-0/2-[bis(2-hydroxyethyl)amino]ethyl oleate
- 147438-27-5/2-Piperidinecarboxylicacid,1-[2-oxo-2-[(2R,3R,6S)-tetrahydro-2-hydroxy-6-[(2S,3E,5E,7E,9S,11R,13R,14R,15E,17R,19E,21R)-14-hydroxy-22-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-2,13-dimethoxy-3,9,11,15,17,21-hexamethyl-12,18-dioxo-3,5,7,15,19-docosapentaen-1-yl]-3-methyl-2H-pyran-2-yl]acetyl]-,(2E,4R,6E,8R)-
- 67047-17-0/N,N-bis(3-methoxyacridin-9-yl)hexane-1,6-diamine
- 821-00-1/hexa-2,4-dienamide
- 27622-90-8/4-METHYL-6-(METHYLTHIO)-1,3,5-TRIAZIN-2-AMINE
- 69151-39-9/benzo[d][1,3]dioxole-4-carboxamide
- 37339-66-5/Thiopeptin B
- 23913-42-0/2,5-bis[(cyclohexyl-methyl-amino)methyl]benzene-1,4-diol
- 1310-98-1/Manganite (Mn(OH)O) (mineral)
- 75949-73-4/Benzenesulfonic acid, 4,4'-[methylenebis[4,1-phenyleneazo( 4,5-dihydro-3-methyl-5-oxo-1H-pyrazole -4,1-diyl)]]bis[3-methyl-, disodium salt
- 136125-52-5/1-(phenylsulfonyl)-5-(prop-2-en-1-yloxy)pyrrolidin-2-one
- 73033-93-9/(8S,9S)-7,12-bis(hydroxymethyl)-8,9-dihydrotetraphene-8,9-diol
- 163133-42-4/b-Alaninamide,(4S)-4-methyl-1-[(4S)-4-methyl-1-oxohexyl]-L-prolyl-(2S,4R,6E)-2-amino-4-methyl-8-oxo-6-decenoyl-(3R)-3-hydroxy-L-leucyl-2-methylalanyl-L-leucyl-L-leucyl-2-methylalanyl-2-methylalanyl-N-[(1S)-2-(dimethylamino)-1-methylethyl]-(9CI)
- 84779-04-4/beta-endorphin, Arg(9,19,24,28,29)-
- 25400-23-1/methanearsonous acid
- 5633-57-8/Benzene,1-methoxy-4-(phenylthio)-
- 4876-02-2/N-[2-(3,4-dimethoxyphenyl)ethyl]-2-phenylacetamide